AmeriPlan launched in 1992 and are based out of Texas in the US.
So the story goes;
In the early 90’s, identical twin brothers Dennis and Daniel Bloom saw the need for a value-oriented discount fee-for-service dental program, and founded AmeriPlan Corporation.
Soon Dennis and Daniel expanded their vision to include a broad array of high quality, affordable healthcare programs.
To provide greater value to the consumer, they added prescription medication, vision and chiropractic care to the program at no additional charge.
Through research, trial and error and perseverance, the brothers determined that by using the best features of the direct sales marketing model, they could provide financial opportunity to thousands of people and bring these needed healthcare programs to the public.
In addition to co-founding AmeriPlan, Dennis Bloom (left) serves as CEO and Chairman of the Board. Daniel Bloom (right) is President and COO.
According to a 2001 article published in Network Marketing Lifestyles Magazine, the Bloom’s corporate experience began with providing marketing services for independent accountants.
As their CPA customer base grew, the Blooms wanted to be able to provide them with one-stop shopping, offering hospitalization, life insurance, mutual funds – whatever they needed.
Soon they started getting requests for a good dental program that independents could afford.
This eventually lead to the formation of a discounted fee-for-service provider access organization.
Their CPA customers loved the program … and so did their customers – The CPA’s were bringing them referrals!
Dennis and Daniel soon realized they were making more money from their little $15-per-month dental program than from everything else they were doing.
Now they knew they had found their niche.
They sold their CPA services company and in November 1992 formally incorporated AmeriPlan to market their own dental program.
On the regulatory side of things, AmeriPlan ran into problems with the Montana State Auditor.
In July, 2006
Montana State Auditor John Morrison issued a cease and desist order after charging AmeriPlan USA, its founding officers, Dennis and Daniel Bloom, and Shirl Shelley, a Montana resident, with numerous violations of both the Montana Insurance Code and the Montana Securities Act.
AmeriPlan
settled the allegations
a few months later for $200,000.
Under the agreement, AmeriPlan must pay an administrative fine of $200,000 and create a restitution fund for Montana customers who were duped by the company.
Montana customers of AmeriPlan can expect to receive a letter informing them that they are eligible to submit a claim to the restitution fund.
In addition, AmeriPlan is banned from marketing and selling its products in Montana for two years.
The problem, as it were, was AmeriPlan had been signing up customers in Montana despite most customers being
unable to use the discount cards because there were few, if any, providers in Montana.
Additio
🤖 Quick Answer
When was AmeriPlan founded and by whom?AmeriPlan was founded in 1992 by identical twin brothers Dennis and Daniel Bloom, based in Texas, United States. The brothers identified a market need for affordable, value-oriented healthcare solutions and established the company to provide discount fee-for-service dental programs, later expanding to include prescription medications, vision care, and chiropractic services.
What services does AmeriPlan offer?
AmeriPlan provides comprehensive discount healthcare programs including dental care, prescription medications, vision care, and chiropractic services. The company operates as a fee-for-service discount plan provider, offering affordable healthcare solutions to consumers without requiring traditional insurance coverage or additional charges for supplementary services.
How does AmeriPlan distribute its programs?
AmeriPlan utilizes a direct sales marketing model to distribute its healthcare programs. This business approach allows the company to generate financial
🔗 Related Articles
- Brent Willis settles NewAge fraud with SEC for $175,000
- Ad Wealth System Review: $25 “unlimited” Ponzi ROIs
- $361 million in WCM777 victim claims disallowed
- Mannatech warned over multiple FDA violations
- $18.2 mill suspended judgment in FTC’s RengaLife case (updates)
